MedTrace Logo

Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)

NCT04731701 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2024-09-19

No results posted yet for this study

Summary

The purpose of this study is to validate the newly developed Hemophilia Functional Ability Scoring Tool (Hemo-FAST), which is a fast and simple scoring in haemophilia able to assess patient-reported functional mobility.

Conditions

Interventions

DIAGNOSTIC_TEST

Hemophilia Joint Health Score (HJHS)

Joint examination with Hemophilia Joint Health Score (HJHS)

Sponsors & Collaborators

  • Kantar Health

    collaborator INDUSTRY

  • Cerner Enviza (former Kantar Health)

    collaborator UNKNOWN

  • Swedish Orphan Biovitrum

    lead INDUSTRY

Principal Investigators

  • Study Physician · Swedish Orphan Biovitrum

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-05
Primary Completion
2022-07-19
Completion
2022-07-19

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04731701 on ClinicalTrials.gov